STOP COVID & EBOLA IN ITS TRACKS WITH CURCUMIN (TUMERIC) - BLOCK ACE2 VIRAL DOCKING

During the Ebola crises I uncovered vast amount of scientific evidence that curcumin blocked Ebola virus spike Glycoprotein from attaching to the body. In other words if you can block the virus from attaching to ACE2 receptor, you can block Ebola. Curcumin did just that. Furthermore I uncovered other research that Curcumin Tumeric was depleted by the body rapidly after infection and that larger amounts were rquired but they did effectively kill the virus by allowing the bodies immune system to catch up. It's a fact that you can block these viruses from entering the body with Tumeric and its also a fact that you can slow down the virus replication with Tumeric which gives the body the time it needs to kill it off even after infection.

Sars-Cov2 requires docking with the same ACE2 receptor. I believe HIV is also the same receptor if my memory serves.

Here is a current study, there thousands of papers on pubmed that back up these findings.

[link to pubs.rsc.org (secure)]

SARS-CoV-2 has resulted in a devastating pandemic with global concern; however, present therapies in virology fail to prevent its effects. Currently, there

is exigency in identifying novel leads with anti-viral properties to impede viral pathogenesis in the host system. Thus, two important curcuminoids of

turmeric, i.e., its curcumin keto and enol forms, were demonstrated to be complementary to bind with the S-glycoprotein and envelope protein of SARS-

CoV-2. However, the keto form of curcumin is more favourable for both these drug targets considering its docking score, binding energy and molecular

dynamics simulation. Thus, this study indicates that surface proteins are key drug target proteins of SARS-CoV-2, and probably curcumin blocks essential

biologically active drug target residues, thereby attenuating the viral infection. Hence, this computational biology approach identifies curcumin as a drug

candidate for further investigation in treating SARS-CoV-2. However, this was an initial study to identify the active pharmacophore of the compound and its

binding site structural complementary for two drug targets. Thus, in the future, we aim to perform large-scale molecular dynamics, and in vitro and in vivo

experiments to confirm the efficacy of curcumin against SARS-CoV-2.

curcumin keto and enol forms

[link to duckduckgo.com (secure)]


More info on Keto Tumneric: pdf

[link to www.chegg.com (secure)]
[link to www.dstuns.iitm.ac.in (secure)]